EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Co‐Delivery of Multiple Toll‐Like Receptor Agonists and Avian Influenza Hemagglutinin on Protein Nanoparticles Enhances Vaccine Immunogenicity and Efficacy

Aaron Ramirez, Jenny E Hernandez-Davies, Aarti Jain, Lu Wang, Erwin Strahsburger, D Huw Davies, Szu-Wen Wang iD

Advanced Healthcare Materials · 2025-04 · 14 (10)

DOI: 10.1002/adhm.202404335 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Healthcare Materials, online erschienen am 09.02.2025. Verfasst von Aaron Ramirez und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemical and Biomolecular Engineering, University of California, Irvine, CA, 92697, USA. Hauptthemen laut MEDLINE: Influenza Vaccines, Nanoparticles, Hemagglutinin Glycoproteins, Influenza Virus, Toll-Like Receptors. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 109 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH HHS, Defense Threat Reduction Agency, National Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Most seasonal and pandemic influenza vaccines are derived from inactivated or attenuated virus propagated in chicken eggs, while more advanced delivery technologies, such as the use of recombinant proteins and adjuvants, are under‐utilized. In this study, the E2 protein nanoparticle (NP) platform is engineered to synthesize vaccines that simultaneously co‐deliver influenza hemagglutinin (H5) antigen, TLR5 agonist flagellin (FliCc), and TLR9 agonist CpG 1826 (CpG) all on one particle (termed H5‐FliCc‐CpG‐E2), with uniform molecular orientation significant for immunomodulation. Antigen‐bound NP formulations elicit higher IgG antibody responses and broader homosubtypic cross‐reactivity against different H5 variants than unconjugated antigen alone. IgG1/IgG2c skewing is modulated by adjuvant type and NP attachment. Conjugation of flagellin to the NP causes significant IgG1 (Th2) skewing while attachment of CpG yields significant IgG2c (Th1) skewing, and simultaneous conjugation of both flagellin and CpG results in a balanced IgG1/IgG2c (Th2/Th1) response. Animals immunized with E2‐based NP vaccines and subsequently challenged with H5N1 influenza show 100% survival, and only animals that receive adjuvanted NP formulations are also protected against morbidity. This investigation highlights that NP‐based delivery of antigen and multiple adjuvants can be designed to effectively modulate the strength, breadth toward variants, and bias of an immune response against influenza viruses.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Influenza VaccinesNanoparticlesHemagglutinin Glycoproteins, Influenza VirusToll-Like ReceptorsImmunogenicity, VaccineAnimalsFlagellinOligodeoxyribonucleotidesMiceAntibodies, ViralFemaleAdjuvants, ImmunologicImmunoglobulin GMice, Inbred BALB CInfluenza A Virus, H5N1 SubtypeToll-Like Receptor Agonists

Stichwörter der Autor:innen

CpGflagellinimmunomodulationinfluenza vaccineprotein nanoparticle

Substanzen

Influenza VaccinesHemagglutinin Glycoproteins, Influenza VirusFlagellinOligodeoxyribonucleotidesAntibodies, ViralToll-Like ReceptorsCpG ODN 1826Adjuvants, ImmunologicImmunoglobulin Ghemagglutinin, avian influenza A virus

Autor:innen und Institutionen

  • Department of Chemical and Biomolecular Engineering, University of California, Irvine, CA, 92697, USA.
  • Vaccine Research and Development Center, Department of Physiology and Biophysics, University of California, Irvine, CA, 92697, USA.
  • Institute for Immunology, University of California, Irvine, CA, 92697, USA.
  • Department of Biomedical Engineering, University of California, Irvine, CA, 92697, USA.
  • Chao Family Comprehensive Cancer Center, University of California, Irvine, CA, 92697, USA.

ORCID-Profile: Szu-Wen Wang

Förderung

  • NIH HHS
  • Defense Threat Reduction Agency
  • National Science Foundation
  • NIBIB NIH HHS
  • NIAID NIH HHS
  • National Institutes of Health

Zitieren

APA

Ramirez, A., Hernandez-Davies, J. E., Jain, A., Wang, L., Strahsburger, E., Davies, D. H., & Wang, S. W. (2025). Co‐Delivery of Multiple Toll‐Like Receptor Agonists and Avian Influenza Hemagglutinin on Protein Nanoparticles Enhances Vaccine Immunogenicity and Efficacy. Advanced Healthcare Materials, 14(10). https://doi.org/10.1002/adhm.202404335

Vancouver

Ramirez A, Hernandez-Davies JE, Jain A, Wang L, Strahsburger E, Davies DH, et al. Co‐Delivery of Multiple Toll‐Like Receptor Agonists and Avian Influenza Hemagglutinin on Protein Nanoparticles Enhances Vaccine Immunogenicity and Efficacy. Advanced Healthcare Materials. 2025;14(10). doi:10.1002/adhm.202404335

BibTeX
@article{Ramirez2025,
  author = {Ramirez, Aaron and Hernandez-Davies, Jenny E and Jain, Aarti and Wang, Lu and Strahsburger, Erwin and Davies, D Huw and Wang, Szu-Wen},
  title = {Co‐Delivery of Multiple Toll‐Like Receptor Agonists and Avian Influenza Hemagglutinin on Protein Nanoparticles Enhances Vaccine Immunogenicity and Efficacy},
  journal = {Advanced Healthcare Materials},
  year = {2025},
  volume = {14},
  number = {10},
  doi = {10.1002/adhm.202404335}
}
Kostenlos starten →